Cost-effective testing does not denote compromise. Through automation, direct raw material origin pipelines, and high-throughput analytical assays, we deliver validated data packages that satisfy global pharmacopeias at fraction of Western CRO costs.
Cellular viability, anti-inflammatory cytokine expression, glucose uptake, and enzymatic inhibition assays providing rapid, cost-effective efficacy screening.
Configure In Vitro Assays
Quantifying secondary metabolite variance across geographical origins and seasonal harvest windows to lock in the highest active yields at optimal acquisition cost.
Explore Origin Screening
Preclinical rodents and disease-induced animal models evaluating pharmacodynamics, metabolic pathways, and targeted organ toxicity with complete histological verification.
Commission Animal Study
HPLC, HPTLC, and GC chromatographic fingerprinting method development and validation per ICH Q2(R1) to definitively verify active purity and prevent adulteration.
Validate Test Method
Complete human clinical research services including IRB/ethics filings, GCP protocol design, small-cohort nutraceutical trials, and Phase I–IV pharmaceutical registration data.
Design Clinical Protocol
High-throughput screening across alkaloid, flavonoid, polysaccharide, and saponin fractions to identify lead pharmacophores with target receptor affinities.
Screen Active Candidates
End-to-end toxicological safety packages: Ames bacterial reverse mutation, chromosomal aberration, micronucleus test, and acute oral LD50 determination.
Request Toxicity Package
Overcoming bioavailability bottlenecks, bad taste profiles, and active degradation to produce scalable capsules, softgels, granules, oral liquids, and functional tablets.
Optimize FormulationEscalating regulatory scrutiny by the FDA, EMA, and NMPA has traditionally driven contract testing budgets into unsustainable territory. Today, global pharmaceutical enterprises and nutraceutical innovators are re-engineering their procurement models around specialized OEM test manufacturers who deliver verified, pharmacopeial-grade data without Western CRO price premiums.
Traditional testing procurement forces enterprise buyers into an uneasy compromise between capital velocity, turnaround timeline, and analytical rigor. High overhead costs at legacy contract laboratories in North America and Western Europe have created barriers for mid-cap pharma and functional food brands seeking extensive biomarker profiling and phytochemical validation.
Affordable testing is fundamentally engineered through modern laboratory automation. By integrating robotic liquid handling systems, ultra-high-performance liquid chromatography coupled with time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), and automated HPTLC densitometry, per-sample processing time is compressed by over 70%, yielding superior reproducibility.
Global consumers and regulatory agencies now reject ambiguous botanical claims. The transition from empirical traditional herbal medicine to quantified, standardized botanical pharmaceuticals necessitates chromatographic fingerprinting, targeted receptor binding affinity assays, and full animal toxicology data before any market rollout or new drug application (NDA).
Headquartered in the biological hub of Changsha, Hunan, MedGence leverages integrated industrial clusters, direct access to authentic Dao Di botanical cultivation bases, and centralized laboratory ecosystems to furnish global buyers with unmatched testing turnaround speed and operational resilience.
Unlike disjointed third-party testing testing brokers who outsource analytical workloads across disconnected labs, our scientific leadership operates under one unified roof. Analytical method development seamlessly transfers into our pilot plant and collaborative GMP manufacturing suites, preventing the critical data loss, delays, and friction inherent in split-vendor supply chains.
Having validated standard testing procedures for nearly 400 single-herb medicines and analyzed hundreds of thousands of research batches, MedGence possesses an extensive internal reference library. This immense historical database slashes exploratory assay development timelines from months to days, drastically lowering total project development expenditures.
Operating under strict bilateral Non-Disclosure Agreements (NDAs), our entrusted research framework treats client formulas, chromatographic elution gradients, and manufacturing process parameters with military-grade secrecy. Proprietary know-how remains exclusively assigned to the client, assuring uncompromised competitive advantages across global markets.
From early-stage botanical active discovery and analytical standardization to preclinical toxicological evaluation, GCP clinical studies, and cGMP commercial contract manufacturing.
Plants contain alkaloids, polysaccharides, saponins and many other bioactive compounds. Using our accumulated phytochemical data and analytical capacity, we identify which substances best deliver your target effect — and which plant sources contain them at the highest density — balancing cost efficiency with environmental sustainability.
View service details
The same species can vary widely in active-ingredient potency depending on growing region, harvest season and the plant part used. We quantify these differences so you can lock in the optimal origin, harvest window and plant part, building a high-yield, cost-effective sourcing strategy.
View service details
A validated test method is the foundation of quality control and market trust. We develop identification and assay methods using HPTLC, HPLC, GC and chromatographic fingerprinting, giving your QC team reliable tools to confirm identity, content and batch-to-batch consistency.
View service details
Once a target ingredient is confirmed, production economics decide competitiveness. We optimize raw-material pretreatment, extraction, purification and drying — the critical parameters that determine yield, purity and scale-up success — while reducing pressure on natural resources.
View service details
Turning actives into consumer products can cause content loss, poor solubility or unpleasant taste. Our process scientists resolve these formulation challenges so the finished product retains its active content and delivers the expected user experience.
View service details
Safety must be proven before a product reaches the market. We perform acute toxicity (LD50), chronic toxicity and genetic toxicity studies, giving you the evidence to launch effective, safe products with confidence.
View service details
Cell- and organ-level assays reveal how tissues respond to an active ingredient at a fraction of the time and cost of in vivo work. In vitro data is especially valuable for go/no-go decisions in programs such as blood-glucose management or antiviral development.
View service details
Toxicity and efficacy studies in animal models provide fast, affordable evidence that a product is effective and harmless — a particularly meaningful reference for dietary supplements and cosmetics before human testing.
View service details
For new actives or formulas developed under contract research, we arrange small-group human trials for dietary supplements as well as Phase I, II, III and IV clinical studies required for a new drug application (NDA).
View service details
Drawing on deep TCM research experience, we design natural formulations that enhance supplement efficacy or form the basis of new medicines — covering formula design, raw-material standards, analytical methods, process improvement, efficacy and toxicity studies, as a full package or as individual tasks.
View service details
Our own pilot plant and partner factories, directly managed by our technical team, transfer study results smoothly into production. Actives are supplied as concentrated liquids, powders, pastes or volatile oils — with your product information kept strictly confidential.
Request specifications
Full contract development and manufacturing for oral liquids, capsules, softgels, tablets, soluble powders and granules — backed by our technical expertise to guarantee timely delivery, reliable quality and non-disclosure of your know-how.
Request specificationsEngage MedGence for an isolated analytical protocol or commission the entire translational lifecycle. Each phase terminates in an audited, regulatory-grade milestone deliverable.
Identify the most effective bioactive compounds and determine the optimal botanical geographic origin, harvest season, and plant anatomical part displaying the highest marker density.
Deliverable: Target & Sourcing Feasibility ReportDevelop and validate high-precision HPTLC, HPLC, GC, and chromatographic fingerprinting methodologies alongside definitive raw-material release quality specifications.
Deliverable: Validated Methods & Monograph SpecsEstablish exact parameters for botanical pretreatment, dynamic solvent extraction, column chromatographic purification, vacuum concentration, and spray-drying scale-up.
Deliverable: Critical Process Parameters (CPP) DossierExecute in vitro target receptor binding assays, cellular metabolic models, and in vivo animal studies including acute oral LD50, chronic toxicology, and GLP genotoxicity screens.
Deliverable: Audited Preclinical Data PackageCoordinate randomized, double-blind, placebo-controlled human trials for dietary claims or complete GCP Phase I–IV clinical investigations required for formal NDA registration.
Deliverable: Biostatistical Clinical Study Report (CSR)Execute validated pilot-scale to commercial-scale cGMP production of standardized concentrated active extracts or finished dosage forms with batch-to-batch consistency guarantees.
Deliverable: Certificate of Analysis & Commercial SupplyOver 14+ years of specialized execution, serving national pharmaceutical conglomerates, Class-3A university medical centers, and international brand owners.
Continuous contract research operations
Ph.D. & Master level chemists & toxicologists
Leading domestic & multinational enterprises
Novel molecules, formulations & assays
Evidence-backed analytical monographs
Advanced botanical drug candidates
Registered hospital medical formulations
Quality benchmarks & active profiles
How overseas brand innovators, pharmaceutical developers, and procurement heads configure our OEM testing services to accelerate compliance and de-risk commercialization.
Scenario: A premier European herbal extract importer faced intermittent supply adulteration and batch inconsistency across imported Ginkgo biloba and Panax ginseng raw lots.
MedGence Execution: Established an automated HPTLC and HPLC fingerprinting assay framework adhering to European Pharmacopoeia (EP) guidelines. By quantifying ratio relationships among hallmark flavonoid glycosides and terpene lactones, adulterants were rapidly detected at a per-test cost 60% below EU domestic contract labs.
Scenario: A US direct-to-consumer nutraceutical leader required rigorous in vitro and animal pharmacological evidence to support cognitive enhancement structure/function claims without triggering FDA warning letters.
MedGence Execution: Delivered a two-tier preclinical package: in vitro acetylcholinesterase (AChE) enzyme inhibition kinetics paired with rodent Morris water maze cognitive performance testing, supplying fully substantiated data files within an 8-week delivery cycle.
Scenario: An Asian-Pacific skincare company developing a patented soothing serum derived from Centella asiatica needed to replace legacy animal tests with alternative OECD-compliant safety and efficacy assays.
MedGence Execution: Implemented in vitro reconstructed human epidermis (RhE) irritation assays (OECD TG 439) combined with trans-epidermal water loss (TEWL) inhibition evaluations, providing definitive non-animal cosmetic testing documentation acceptable to international authorities.
Our contract testing and R&D pipelines power major public pharmaceutical corporations, research universities, and hospital preparation centers across Asia and overseas markets.
China Beijing Tongrentang
CR Sanjiu Pharmaceutical
Sunflower Pharmaceutical
Livzon Pharmaceutical Group
Dihon Pharmaceutical
Golden Throat Holdings
Yangtzi River Pharma
Beihai Gofar Biological
Humanwell Healthcare
SCIMYTH Pharmaceutical
Shandong Hanfang Pharma
Luoxin Pharmaceutical
Guangdong Zhongsheng
Brilliance & Abundance
Apeloa Pharmaceutical
Hunan Heng Chang Pharma
Baotou TCM Pharma
Kamp Medicine
Guangxi Santo Pharma
Hunan Kangshou Pharma
Jiangxi Juwang Industry
Beijing Tcmages Pharma
Guizhou Ruihe Pharma
Anhui CR Jinchan
Kangmei Pharmaceutical
Hunan Tianjicaotang
Jiangxi Kingstone Unite
Shuguang Hospital, Shanghai TCM
Hunan Direct TCM Hospital
1st Hosp. Hunan Univ. of CM
2nd Xiangya Hosp. CSU
2nd Hosp. Hunan Univ. of CM
Zhuzhou TCM Orthopedics
Critical inquiries addressing analytical validation, cost mechanisms, sample shipping, IP protection, and data governance for enterprise sourcing directors.
Connect directly with our senior study directors. Explore specific assay packages, review technical instrumentation benchmarks, and receive a binding feasibility proposal within 48 business hours.
Cellular viability, anti-inflammatory cytokine expression, glucose uptake, and enzymatic inhibition assays providing rapid, cost-effective efficacy screening.
Configure In Vitro Assays
Quantifying secondary metabolite variance across geographical origins and seasonal harvest windows to lock in the highest active yields at optimal acquisition cost.
Explore Origin Screening
Preclinical rodents and disease-induced animal models evaluating pharmacodynamics, metabolic pathways, and targeted organ toxicity with complete histological verification.
Commission Animal Study
HPLC, HPTLC, and GC chromatographic fingerprinting method development and validation per ICH Q2(R1) to definitively verify active purity and prevent adulteration.
Validate Test Method
Complete human clinical research services including IRB/ethics filings, GCP protocol design, small-cohort nutraceutical trials, and Phase I–IV pharmaceutical registration data.
Design Clinical Protocol
High-throughput screening across alkaloid, flavonoid, polysaccharide, and saponin fractions to identify lead pharmacophores with target receptor affinities.
Screen Active Candidates
End-to-end toxicological safety packages: Ames bacterial reverse mutation, chromosomal aberration, micronucleus test, and acute oral LD50 determination.
Request Toxicity Package
Overcoming bioavailability bottlenecks, bad taste profiles, and active degradation to produce scalable capsules, softgels, granules, oral liquids, and functional tablets.
Optimize Formulation